Transforming Colon Cancer Treatment: The Impact of Pembrolizumab Recent groundbreaking findings from the RESET-C study have shown promising results for patients with deficient mismatch repair (dMMR) colon cancer, sparking significant interest in the medical community. The study revealed that a single cycle of neoadjuvant pembrolizumab might be enough to achieve a pathologic complete response in … Read more
A Deep Dive into the Risk of Ovarian Cancer Associated with Endometriosis Recent research published in JAMA, as highlighted by Dr. Maurie Markman from City of Hope, presents compelling data that challenges current thinking around ovarian cancer risk assessment. This study, aptly titled “Endometriosis Typology and Ovarian Cancer Risk,” delves into the nuances of how … Read more
Revolutionizing Intraoperative Decision-Making: The Role of IFSH in HPV-related Head and Neck Cancers Frozen section histopathology (IFSH) continues to be a cornerstone in surgical oncology, especially for its ability to guide intraoperative re-resections and improve patient outcomes. A recent study led by Dr. Salma Ramadan at Washington University School of Medicine highlights both the strengths … Read more
Unveiling New Horizons: Chemotherapy in Endometrial Cancer Treatment A groundbreaking study recently published in the Journal of Clinical Oncology offers fresh insights into the management of recurrent endometrial cancer. Dr. Maurie Markman from City of Hope brings light to this significant research, highlighting the surprising outcomes concerning chemotherapy and radiation therapy. Understanding the Study’s Scope … Read more